A detailed history of Cibc Private Wealth Group, LLC transactions in Biodesix Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 29,337 shares of BDSX stock, worth $46,059. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,337
Previous 29,337 -0.0%
Holding current value
$46,059
Previous $44,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$1.21 - $1.71 $19,646 - $27,765
16,237 Added 123.95%
29,337 $44,000
Q4 2022

Feb 13, 2023

BUY
$0.98 - $2.3 $12,838 - $30,129
13,100 New
13,100 $30,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $62.8M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.